Titre : Triacylglycerol lipase

Triacylglycerol lipase : Questions médicales fréquentes

Termes MeSH sélectionnés :

Immunotherapy
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Triacylglycerol lipase : Questions médicales les plus fréquentes", "headline": "Triacylglycerol lipase : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Triacylglycerol lipase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-13", "dateModified": "2025-03-10", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Triacylglycerol lipase" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Carboxylic ester hydrolases", "url": "https://questionsmedicales.fr/mesh/D002265", "about": { "@type": "MedicalCondition", "name": "Carboxylic ester hydrolases", "code": { "@type": "MedicalCode", "code": "D002265", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.352.100" } } }, "about": { "@type": "MedicalCondition", "name": "Triacylglycerol lipase", "alternateName": "Lipase", "code": { "@type": "MedicalCode", "code": "D008049", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Luciana R B Gonçalves", "url": "https://questionsmedicales.fr/author/Luciana%20R%20B%20Gon%C3%A7alves", "affiliation": { "@type": "Organization", "name": "Departamento de Engenharia Química, Universidade Federal do Ceará, Campus do Pici, Bloco 709, Fortaleza 60455760, CE, Brazil." } }, { "@type": "Person", "name": "Roberto Fernandez-Lafuente", "url": "https://questionsmedicales.fr/author/Roberto%20Fernandez-Lafuente", "affiliation": { "@type": "Organization", "name": "Departamento de Biocatálisis, ICP-CSIC, Campus UAM-CSIC, 28049 Madrid, Spain. rfl@icp.csic.es." } }, { "@type": "Person", "name": "Yonghua Wang", "url": "https://questionsmedicales.fr/author/Yonghua%20Wang", "affiliation": { "@type": "Organization", "name": "School of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China. yonghw@scut.edu.cn." } }, { "@type": "Person", "name": "Rodolpho R C Monteiro", "url": "https://questionsmedicales.fr/author/Rodolpho%20R%20C%20Monteiro", "affiliation": { "@type": "Organization", "name": "Departamento de Engenharia Química, Universidade Federal do Ceará, Campus do Pici, Fortaleza, Brazil." } }, { "@type": "Person", "name": "Pierre B A Fechine", "url": "https://questionsmedicales.fr/author/Pierre%20B%20A%20Fechine", "affiliation": { "@type": "Organization", "name": "Group of Chemistry of Advanced Materials (GQMat) - Department of Analytical Chemistry and Physic-chemistry, Federal University of Ceará - UFC, Fortaleza, Brazil." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Nanoparticle-mediated blockade of CXCL12/CXCR4 signaling enhances glioblastoma immunotherapy: Monitoring early responses with MRI radiomics.", "datePublished": "2024-02-14", "url": "https://questionsmedicales.fr/article/38360292", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.actbio.2024.02.007" } }, { "@type": "ScholarlyArticle", "name": "Case report: A rare case of immunotherapy induced isolated left CN VI palsy in a patient with unresectable melanoma.", "datePublished": "2024-02-12", "url": "https://questionsmedicales.fr/article/38410107", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fonc.2024.1330271" } }, { "@type": "ScholarlyArticle", "name": "Molecular basis, potential biomarkers, and future prospects of OSCC and PD-1/PD-L1 related immunotherapy methods.", "datePublished": "2024-02-10", "url": "https://questionsmedicales.fr/article/38380036", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.heliyon.2024.e25895" } }, { "@type": "ScholarlyArticle", "name": "Efficacy of biological agents combined with oral immunotherapy (OIT) for food allergy: a protocol for a systematic review and meta-analysis.", "datePublished": "2024-02-07", "url": "https://questionsmedicales.fr/article/38326257", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2023-075253" } }, { "@type": "ScholarlyArticle", "name": "Management of patients with extensive small-cell lung cancer in the immunotherapy era: an Italian consensus through a Delphi approach.", "datePublished": "2024-01-31", "url": "https://questionsmedicales.fr/article/38307393", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.critrevonc.2023.104247" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Hydrolases", "item": "https://questionsmedicales.fr/mesh/D006867" }, { "@type": "ListItem", "position": 5, "name": "Esterases", "item": "https://questionsmedicales.fr/mesh/D004950" }, { "@type": "ListItem", "position": 6, "name": "Carboxylic ester hydrolases", "item": "https://questionsmedicales.fr/mesh/D002265" }, { "@type": "ListItem", "position": 7, "name": "Triacylglycerol lipase", "item": "https://questionsmedicales.fr/mesh/D008049" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Triacylglycerol lipase - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Triacylglycerol lipase", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Triacylglycerol lipase", "description": "Comment diagnostiquer une déficience en lipase ?\nQuels tests sont utilisés pour évaluer la lipase ?\nQuels symptômes indiquent un problème de lipase ?\nLa lipase est-elle mesurée lors d'une pancréatite ?\nQuels autres marqueurs sont associés à la lipase ?", "url": "https://questionsmedicales.fr/mesh/D008049?mesh_terms=Immunotherapy&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Triacylglycerol lipase", "description": "Quels sont les symptômes d'une hyperlipidémie ?\nComment la déficience en lipase se manifeste-t-elle ?\nLa lipase affecte-t-elle le poids corporel ?\nQuels signes indiquent une inflammation pancréatique ?\nLes douleurs abdominales sont-elles liées à la lipase ?", "url": "https://questionsmedicales.fr/mesh/D008049?mesh_terms=Immunotherapy&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Triacylglycerol lipase", "description": "Comment prévenir les troubles liés à la lipase ?\nLes examens réguliers sont-ils nécessaires ?\nLe contrôle du poids aide-t-il la lipase ?\nLes habitudes alimentaires influencent-elles la lipase ?\nL'exercice régulier est-il bénéfique ?", "url": "https://questionsmedicales.fr/mesh/D008049?mesh_terms=Immunotherapy&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Triacylglycerol lipase", "description": "Comment traiter une déficience en lipase ?\nQuels médicaments peuvent affecter la lipase ?\nLa lipase peut-elle être ciblée par des thérapies ?\nQuels changements alimentaires aident la lipase ?\nLes enzymes pancréatiques sont-elles efficaces ?", "url": "https://questionsmedicales.fr/mesh/D008049?mesh_terms=Immunotherapy&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Triacylglycerol lipase", "description": "Quelles complications peuvent survenir avec une lipase élevée ?\nLa lipase affecte-t-elle la santé cardiovasculaire ?\nQuels risques sont associés à une déficience en lipase ?\nLes troubles lipidiques peuvent-ils causer des AVC ?\nUne lipase anormale peut-elle affecter le foie ?", "url": "https://questionsmedicales.fr/mesh/D008049?mesh_terms=Immunotherapy&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Triacylglycerol lipase", "description": "Quels facteurs augmentent le risque de troubles lipidiques ?\nL'hérédité joue-t-elle un rôle dans les troubles lipidiques ?\nLe tabagisme influence-t-il la lipase ?\nLe stress a-t-il un impact sur la lipase ?\nL'âge est-il un facteur de risque pour la lipase ?", "url": "https://questionsmedicales.fr/mesh/D008049?mesh_terms=Immunotherapy&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en lipase ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins mesurant les niveaux de lipase peuvent indiquer une déficience." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la lipase ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de lipase sérique sont couramment utilisés pour évaluer la fonction pancréatique." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème de lipase ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales, des nausées et des vomissements peuvent signaler un problème." } }, { "@type": "Question", "name": "La lipase est-elle mesurée lors d'une pancréatite ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les niveaux de lipase sont souvent élevés en cas de pancréatite aiguë." } }, { "@type": "Question", "name": "Quels autres marqueurs sont associés à la lipase ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'amylase est souvent mesurée en parallèle pour évaluer les troubles pancréatiques." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une hyperlipidémie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs abdominales, des éruptions cutanées et une fatigue." } }, { "@type": "Question", "name": "Comment la déficience en lipase se manifeste-t-elle ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des malabsorption des graisses, des diarrhées grasses et des carences nutritionnelles." } }, { "@type": "Question", "name": "La lipase affecte-t-elle le poids corporel ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une déficience peut entraîner une perte de poids due à une mauvaise absorption des graisses." } }, { "@type": "Question", "name": "Quels signes indiquent une inflammation pancréatique ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales sévères, des nausées et des vomissements sont des signes d'inflammation." } }, { "@type": "Question", "name": "Les douleurs abdominales sont-elles liées à la lipase ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux anormaux de lipase peuvent être associés à des douleurs abdominales." } }, { "@type": "Question", "name": "Comment prévenir les troubles liés à la lipase ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une alimentation équilibrée et un mode de vie actif peut aider à prévenir les troubles." } }, { "@type": "Question", "name": "Les examens réguliers sont-ils nécessaires ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers peuvent aider à détecter précocement des anomalies lipidiques." } }, { "@type": "Question", "name": "Le contrôle du poids aide-t-il la lipase ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, maintenir un poids santé peut réduire le risque de troubles lipidiques." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles la lipase ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses saturées peut affecter les niveaux de lipase." } }, { "@type": "Question", "name": "L'exercice régulier est-il bénéfique ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier aide à réguler le métabolisme lipidique et la lipase." } }, { "@type": "Question", "name": "Comment traiter une déficience en lipase ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des suppléments enzymatiques pour améliorer la digestion." } }, { "@type": "Question", "name": "Quels médicaments peuvent affecter la lipase ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments comme les diurétiques peuvent influencer les niveaux de lipase." } }, { "@type": "Question", "name": "La lipase peut-elle être ciblée par des thérapies ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies ciblées peuvent être développées pour traiter des troubles lipidiques spécifiques." } }, { "@type": "Question", "name": "Quels changements alimentaires aident la lipase ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en fibres et faible en graisses saturées peut améliorer la santé lipidique." } }, { "@type": "Question", "name": "Les enzymes pancréatiques sont-elles efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles aident à la digestion des graisses en cas de déficience en lipase." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une lipase élevée ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Une lipase élevée peut indiquer une pancréatite, entraînant des complications graves." } }, { "@type": "Question", "name": "La lipase affecte-t-elle la santé cardiovasculaire ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux élevés de lipides peuvent augmenter le risque de maladies cardiovasculaires." } }, { "@type": "Question", "name": "Quels risques sont associés à une déficience en lipase ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une déficience peut entraîner des malnutritions et des carences en vitamines liposolubles." } }, { "@type": "Question", "name": "Les troubles lipidiques peuvent-ils causer des AVC ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles lipidiques non traités peuvent augmenter le risque d'accidents vasculaires cérébraux." } }, { "@type": "Question", "name": "Une lipase anormale peut-elle affecter le foie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux anormaux peuvent être liés à des maladies hépatiques comme la stéatose." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de troubles lipidiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'obésité, le diabète et une alimentation riche en graisses saturées augmentent le risque." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle dans les troubles lipidiques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de troubles lipidiques peuvent augmenter le risque." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il la lipase ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut affecter le métabolisme lipidique et les niveaux de lipase." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur la lipase ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut influencer le métabolisme et les niveaux de lipase." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour la lipase ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de troubles lipidiques augmente avec l'âge en raison de changements métaboliques." } } ] } ] }

Sources (10000 au total)

Case report: A rare case of immunotherapy induced isolated left CN VI palsy in a patient with unresectable melanoma.

Immune checkpoint inhibitors are the mainstay of treatment in patients with unresectable or metastatic melanoma. Combination immunotherapy with ipilimumab and nivolumab has shown to improve survival o... A 66-year-old woman with a background of metastatic, unresectable melanoma with supraclavicular and axillary lymph nodal involvement presented with a headache, photophobia and diplopia 3 weeks after h... This is the first reported UK case of immunotherapy-induced isolated cranial nerve VI palsy. Multiple irAEs are more common with combination immunotherapy and its occurrence is associated with more fa...

Efficacy of biological agents combined with oral immunotherapy (OIT) for food allergy: a protocol for a systematic review and meta-analysis.

Food allergy affects a large population throughout the world. Recently, oral immunotherapy (OIT) has been reported as an effective treatment for severe food allergy. Although OIT was successful in num... This paper provides a protocol for a systematic review of the relevant published analytical studies using an aggregate approach following the Preferred Reporting Items for Systematic Review and Meta-A... The protocol of this systematic review will be provided in a peer-reviewed journal. As the researchers will not identify the individual patients included in the studies, they do not need to acquire et... CRD42022373015....

Management of patients with extensive small-cell lung cancer in the immunotherapy era: an Italian consensus through a Delphi approach.

Immunotherapy represented a turning point for treating extensive small-cell lung cancer (ES-SCLC). Although, many issues remain debated.... A group of Italian medical and radiation oncologists with expertise in managing patients with ES-SCLC developed a list of statements divided in six areas of interest. The Delphi method was used to ass... 32 statements were included in the final list to be voted by the Delphi panel, and 26 reached a consensus on the agreement. A prompt involvement of a multidisciplinary team is a priority to provide an... While awaiting new data from clinical trials and real-world studies, these recommendations can represent a useful tool to guide the management of ES-SCLC patients in daily practice....

Dynamic immune signatures of patients with advanced non-small-cell lung cancer for infection prediction after immunotherapy.

Pulmonary infections are a crucial health concern for patients with advanced non-small-cell lung cancer (NSCLC). Whether the clinical outcome of pulmonary infection is influenced by immunotherapy(IO) ... Blood specimens were prospectively collected from patients with NSCLC before and after chemotherapy(C/T) and/or IO to explore dynamic changes in immune signatures. Real-world clinical data were extrac... The retrospective cohort included 283 patients with advanced NSCLC. IO was associated with a lower risk of pneumonia (odds ratio=0.46, p=0.012). Patients receiving IO and remained pneumonia-free exhib... Our results indicate that the incorporation of immunotherapy into treatment regimens may potentially offer protective effects against pulmonary infection. Protective effects are associated with reduct...